tiprankstipranks
Company Announcements

Pharmaxis Ltd Reveals Interim Results at Hematology Forum

Story Highlights
Pharmaxis Ltd Reveals Interim Results at Hematology Forum

Discover the Best Stocks and Maximize Your Portfolio:

Pharmaxis Ltd ( (AU:SNT) ) has issued an update.

Pharmaxis Ltd presented interim results at the 66th American Society of Hematology annual meeting, with further data expected in 2025. These results, while preliminary, are part of the company’s ongoing efforts to develop and commercialize its product pipeline, which may influence its strategic direction and stakeholder interest.

More about Pharmaxis Ltd

YTD Price Performance: -12.50%

Average Trading Volume: 4,896,654

Technical Sentiment Consensus Rating: Hold

Current Market Cap: A$110.6M

Learn more about SNT stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1